1. Introduction {#s0005}
===============

Leishmaniases are a group of infectious diseases caused by protozoan *Leishmania* parasites and are transmitted by the bites of infected female phlebotomine sandflies ([@bb0090]). These diseases are currently endemic in 98 countries worldwide ([@bb0120]), with up to 1 million new cases being estimated to occur annually ([@bb0115]). Leishmaniases are highly prevalent in North Africa ([@bb0010]), with cutaneous leishmaniasis (CL) being a major public health problem in Morocco, where it is caused by three *Leishmania* species: (1) *L. major*, which is the causative agent of zoonotic CL, the first form to be described in Morocco by Foley and Vialate in 1914 ([@bb0100]); (2) *L. tropica*, which is the causative agent of anthroponotic CL and (3) *L*. *infantum*, which is responsible for sporadic CL in northern areas where zoonotic visceral leishmaniasis has been endemic since 1920 ([@bb0060]). The annual frequency of documented patients with CL fluctuates across years, with 8707 reported cases in 2010 ([@bb0120]).

Several issues are faced when attempting to prevent the spread of CL in Morocco, including the geographical expansion of the disease to new areas where it was previously unknown, particularly of CL caused by L. *tropica*; the heterogeneity of lesion appearance and the difficulty in diagnosing CL, all of which contribute to the late diagnosis of CL and delayed treatment of patients. *Leishmania tropica* is the *Leishmania* species with the widest geographical distribution in Morocco and the highest incidence in North Africa ([@bb0010]). Therefore, the objective of this study was to describe the epidemiological and clinical profiles of patients with CL diagnosed at Ibn Rochd University Hospital in Casablanca (Morocco), which is a non-endemic area for CL.

2. Patients and methods {#s0010}
=======================

2.1. Ethics statements {#s0015}
----------------------

This study was conducted according to the principles specified in the Declaration of Helsinki and the local ethical guidelines of the Ethics Committee for Biomedical Research of the Faculty of Medicine and Pharmacy, University Hassan II of Casablanca, Morocco (International Review Board 00002504). Dermal tissue aspirates are routinely sampled by a dermatologist at the Department of Dermatology, University Hospital Ibn Rochd, Casablanca, for parasitological confirmation of CL prior to any treatment prescription. The confidentiality of personal and clinical data was guaranteed, and the entire dataset was processed anonymously.

2.2. Description of the study area {#s0020}
----------------------------------

Casablanca is a large industrialised city situated on the Atlantic coast in the Casablanca-Settat region of northwest Morocco. This region is predominantly urban (urbanisation rate = 92.9% in 2008) and has high industrial activity ([@bb0055]). According to the Moroccan Ministry of Health data, Casablanca is a non-endemic city for CL ([@bb0080]).

2.3. Epidemiological and clinical data {#s0025}
--------------------------------------

A cross-sectional study was conducted in Casablanca between 2010 and 2016, during which several variables were collected from patients who met the inclusion criteria, as outlined below.

### 2.3.1. Inclusion criteria {#s0030}

All patients who presented to the Department of Dermatology and Venereology of Casablanca Ibn Rochd University Hospital and met the following WHO criteria ([@bb0115]) were included: ≥1 lesions suggestive of CL presenting as papule or nodule, ulcerated or not, evolving for several weeks on the uncovered parts of their body, that had appeared since September and persisted after 3 weeks of usual therapeutics (i.e. antiseptics and local antibiotics) independently from any history of travel or residency in known endemic areas for CL in Morocco based on data from the Ministry of Health ([Fig. 1](#f0005){ref-type="fig"}).Fig. 1Map showing the location of the endemic foci of cutaneous leishmaniasis due to *Leishmania major* (blue dots) and L. *tropica* (red dots) in Morocco according to [@bb0065].Fig. 1

No limitation in terms of age or sex of patients was considered. Finally, only patients with positive polymerase chain reaction (PCR) and genotyping results were analysed in this study, regardless of their epidemiological and clinical data.

### 2.3.2. Epidemiological and clinical variables {#s0035}

The following variables were recorded for each patient: age, sex, geographic origin of the infection, date of onset, disease duration at diagnosis, clinical presentation (papule, nodule, ulcer, vegetant/verrucous, lupoid, subcutaneous nodule and red halo), body location and size of dermal lesions. Any information related to travel to known endemic areas and the presence of similar cases in the family was also noted ([Appendix A](#s0075){ref-type="sec"}).

2.4. Diagnosis of CL {#s0040}
--------------------

Samples were obtained from all patients who met the inclusion criteria for parasitological and molecular diagnosis. This was conducted at the Laboratory of Parasitology of the Faculty of Medicine and Pharmacy, University Hassan II of Casablanca.

Dermal fluid was collected from the border of active skin lesions in each patient using a syringe, and diagnosis was made through direct examination, parasite culture and restriction fragment length polymorphism analysis of PCR-amplified internal transcribed spacer 1 region (ITS1 PCR-RFLP), as described by [@bb0085]. The disease was confirmed when the results of direct examination, culture and/or PCR were positive.

2.5. Statistical analysis {#s0045}
-------------------------

A simple descriptive analysis of data was first performed, in which quantitative variables are expressed as mean ± standard deviations and qualitative variables as percentages. Bivariate analysis was performed to examine possible associations among some variables using the chi-square and Fisher\'s exact tests for qualitative variables and Student\'s *t*-test for quantitative variables. Finally, multivariate logistic regression analysis was performed to estimate adjusted odds ratio and its 95% confidence interval for each selected factor (conservative threshold = 0.20). Outcome variable was genotyped *Leishmania* species, and regression model predictors were age and sex of patients, place of residence, similar cases in the family, clinical aspects, size and location of lesions, multiple or single lesions and incubation time. All statistical tests were bilateral and were performed using the SPSS 16.0 software using a threshold of Pearson\'s stability of 0.05.

3. Results {#s0050}
==========

Over the 7-year study period, 106 cases of CL were diagnosed and genotyped, among which 61 (57.5%) were caused by L. *tropica*, 38 (35.9%) by L. *major* and 7 (6.6%) by L. *infantum*. Because only few cases were caused by L. *infantum*, only epidemiological data of patients with CL caused by L. *tropica* and L. *major* were included in subsequent analyses (n = 99; [Table 1](#t0005){ref-type="table"}; [Appendix B](#s0080){ref-type="sec"}).Table 1Epidemiological characteristics of patients diagnosed with cutaneous leishmaniasis caused by *Leishmania tropica* and L. *major* in Casablanca between 2010 and 2016.Table 1Patients n = 99 (%)*p*-valueOdds ratioMultivariate logistic regression 95% CI*p*-value*L. tropica*\
n = 61(61.6)*L. major*\
n = 38(38.4)Age (mean ± SD)25.5 ± 23.541.2 ± 22.90.0021.0251.006--1.0450.012Sex Male25 (41.0)14 (36.8)0.423------ Female36 (59.0)24 (63.2)Place of residence Urban and peri-urban16 (26.2)7 (18.4)0.984------ Rural42 (68.8)28 (73.7) Not determined3 (5.0)3 (7.9)Similar cases in the family[a](#tf0005){ref-type="table-fn"}19 (31.1)11 (29.0)0.500------[^1][^2]

There was a slight female bias in the susceptibility of patients to CL caused by L. *tropica* and *L*. *major*, but this was not statistically significant. All age groups were affected by CL caused by both species, but CL caused by L. *tropica* was more frequently diagnosed in children aged 0--9 years (*p* = 0.005), whereas CL caused by L. *major* was more frequently diagnosed in elderly patients aged \>50 years (*p* = 0.004) ([Fig. 2](#f0010){ref-type="fig"}). Consequently, the mean age of patients with CL caused by L. *tropica* was significantly lower than that of patients with CL caused by L. *major* (25 ± 23.5 vs. 41 ± 22.9, respectively; *p* = 0.002).Fig. 2Distribution of patients in different age categories who were diagnosed with cutaneous leishmaniasis caused by *Leishmania tropica* and L. *major* in Casablanca between 2010 and 2016.Fig. 2

Among the patients who were included in the analysis, 75% (74/99) had a history of travelling to other known endemic areas in Morocco and 20% (20/99) resided in the endemic focus where they were infected, whereas the remaining 5% (5/99) had no history of residence in or travel to a known focus. Overall, the frequency of CL was not significantly associated with a history of residing in urban/peri-urban or rural endemic regions. Furthermore, 63.2% (24/38) of patients with CL caused by L. *major* were infected in the same southern endemic region (Daraa Tafilalet), whereas L. *tropica* infections occurred in 9 different endemic regions, with 26.2% (16/61) of these patients also being infected in Daraa Tafilalet ([Fig. 1](#f0005){ref-type="fig"}, [Appendix C](#s0085){ref-type="sec"}). There was no association between the residence of patients with CL in endemic foci and the presence of similar cases in their family.

Clinically, the appearance of lesions was heterogeneous ([Table 2](#t0010){ref-type="table"}). Dermal lesions presented mainly as papules, nodules and ulcers, with no significant difference in terms of appearance of these lesions between CL caused by L. *major* and that by L. *tropica*. However, there was a significant difference in the location and size of lesions caused by the two species, with lesions resulting from L. *major* mainly occurring on the lower limbs (*p* = 0.001) and those resulting from L. *tropica* mainly occurring on the face (*p* = 0.001) and being significantly smaller (\<2 cm; *p* = 0.001). Furthermore, 90.5% (86/95) of the patients presented with lesions that had been developing for \>2 months at the time of diagnosis, whereas 33.7% (32/95) had lesions that had been developing for \>6 months ([Appendix D](#s0090){ref-type="sec"}).Table 2Clinical characteristics of patients diagnosed with cutaneous leishmaniasis caused by *Leishmania tropica* and L. *major* in Casablanca between 2010 and 2016.Table 2CharacteristicPatients n = 99 (%)*p*-valueOdds ratioMultivariate logistic regression 95% CI*p*-value*L. tropica*\
n = 61(61.6)*L. major*\
n = 38 (38.4)Clinical aspects (n = 215 lesions) Cicatricial lesion/scar3 (2.3)3 (3.7)0.673------ Papule28 (21.0)12 (14.6)0.1580.9310.338--0.5670.891 Nodule49 (36.9)29 (35.4)0.635------ Ulcer19 (14.3)18 (22.0)0.1051.0120.357--2.8640.983 Vegetant/verrucous7 (5.3)6 (7.3)0.554------ Lupoid5 (3.7)3 (3.6)1.000------ Subcutaneous nodule1 (3.7)1 (1.2)1.000------ Purple red halo21 (15.8)10 (12.2)0.397------Size \<2 cm38 (62.3)9 (23.7)0.0014.3781.694--11.3130.002 ≥2 cm23 (37.7)29 (76.3)Lesion body location (n = 123 lesions) Face46 (62.2)15 (30.6)0.0010.2640.105--0.6640.005 Upper limb17 (23.0)15 (30.6)0.230------ Lower limb10 (13.5)17 (34.7)0.0010.2640.382--5.0840.615 Trunk1 (1.3)2 (4.1)0.557------Single lesion30 (49.2)17 (44.7)0.667------Multiple lesions31 (50.8)21 (55.3)0.667------Incubation time[a](#tf0010){ref-type="table-fn"} \<4 months23 (53.4)13 (44.8)0.471------ ≥4 months20 (46.6)16 (55.2)[^3][^4]

Finally, multivariate linear regression analysis (ascending Wald) showed that three clinical variables were highly associated with CL caused by L. *tropica*: lesion size (*p* = 0.002), location on the face (*p* = 0.005) and young age of patients ([Table 1](#t0005){ref-type="table"}; *p* = 0.012).

4. Discussion {#s0055}
=============

Our analysis of patients with CL diagnosed at Ibn Rochd Hospital showed that three *Leishmania* species are responsible for CL in Casablanca, with L. *tropica* (57.5%) and L. *major* (35.9%) causing the highest number of cases, which reflects the national situation of Morocco. The low frequency of L. *infantum* genotype suggests that this zoonotic form occurs sporadically or is under-recognised and consequently under-diagnosed.

Moroccan foci of zoonotic CL are located in a large area stretching from the Atlantic coast south of the Anti-Atlas Mountains to the northeast of the country ([Fig. 1](#f0005){ref-type="fig"}). Zoonotic CL caused by L. *major* became an epidemic in southern arid regions at the end of the 1970s, with alternating endemic and epidemic cycles ([@bb0105]). However, over the last decade, there has been an unusual persistence of the epidemics, with annual and regional fluctuations ([@bb0110]). The factors that influence the spatial and temporal dynamics of zoonotic CL are not well understood but may include the dynamics of rodent populations, dispersal of vectors, climate changes, vegetation and soil types as well as high density of human populations in areas where the sylvatic transmission of leishmaniasis is high (rodent--vector--rodent cycle) ([@bb0110]; [@bb0050]).

In our passive survey of patients with CL in the non-endemic region of Casablanca between 2010 and 2016, 75% had a history of travel to endemic regions of Morocco, highlighting the potential risk of being infected with *Leishmania* when travelling to endemic areas. Furthermore, while 63.2% of patients with CL caused by L. *major* were infected in the same highly endemic region, patients with CL caused by L. *tropica* were infected in 9 different regions, illustrating the tendency of this species to expand geographically into new areas that were previously non-endemic ([@bb0080]). Over the last few decades, *L*. *tropica* foci have spread to several regions of Morocco including those that previously reported CL caused by L. *major* or L. *infantum*. Indeed, [@bb0005] recently reported the presence of all three *Leishmania* species responsible for CL in a region that was traditionally considered endemic for zoonotic CL caused by L. *major*, demonstrating the changing geographical patterns of these species, particularly L. *tropica*. Furthermore, [@bb0045] conducted an epidemiological study on cases of CL in 6 provinces in southwestern Morocco between 2000 and 2016, and ITS1 PCR-RFLP revealed the presence of L. *tropica* in all six of these provinces.

The North African form of CL caused by L. *tropica* remains clearly distinguishable from the anthroponotic urban and hyper-endemic CL observed in cities in the Middle East and Central Asia ([@bb0010]). During the 1980s, this North African form prevailed in scattered hypo-endemic rural foci and small towns located in the arid mountains where the disease was sporadic. However, since the late 1990s, several epidemics with hundreds of cases have been reported in several Moroccan cities ([@bb0095]), possibly as a result of migrations and population movements from endemic to non-endemic cities as well as human population growth in poor habitat. The introduction of leishmaniasis to a new area relies on a well-established sandfly population to act as a vector. The extended geographical distribution of *Phlebotomus sergenti*, which is the proven vector of L. *tropica* in Morocco, resulted in the spread of anthroponotic CL in both rural and urban/peri-urban areas ([@bb0065]). [@bb0125] showed that nearly all mitochondrial DNA haplotypes and lineages of *P*. *sergenti* in Morocco have marked regionality, suggesting that they have undergone natural dispersal that was not human assisted. No autochthonous cases of anthroponotic CL have been detected in the Iberian Peninsula, despite *P*. *sergenti* commonly being found at sufficient densities to act as a vector. However, [@bb0075] found that one lineage appears to have adaptive advantages (a wider tolerance to temperature and altitude) that would make it better suited to leading geographical expansion into the rest of Europe. Thus, this risk should be assessed by conducted entomological surveys in peri-urban areas of Morocco to search for vector species and determine *Leishmania* infection rates.

We detected a slightly but not significantly higher rate of CL caused by L. *tropica* and L. *major* in females than in males, consistent with the findings of previous studies ([@bb0070]; [@bb0025]). Furthermore, in a recent zoonotic CL outbreak in Morocco, significantly more females were infected than males ([@bb0050]). Several surveys have shown that women and children may consult medical professionals more frequently for aesthetic reasons and the potential social impact of the lesions ([@bb0030]) because although these lesions heal spontaneously, they can cause facial scars, which can lead to a social stigma, particularly among women.

Patients who were included in our study were aged from 7 months to 85 years. The age at which people are affected by CL seems to depend on the parasite transmission intensity (force of infection) to which the population is exposed. In established endemic CL foci, the prevalence generally increases with age up to 15 years, after which it stabilises, probably reflecting the progressive acquisition of immunity ([@bb0050]). However, most patients with CL caused by L. *tropica* were aged \<9 years, whereas most patients with CL caused by L. *major* were aged \>50 years. The active geographical spread of L. *tropica* leading to new epidemic foci may, at least in part, explain why young patients are more exposed to infection because they will be immunologically naive and lack or have low specific anti-*Leishmania* immunity ([@bb0040]). To better understand why patients aged \>50 years more often presented with CL caused by L. *major*, we compared the dates of diagnosis with the epidemiological situation in the province where they were infected the previous summer, according to the reports of the Ministry of Health. However, we found no correlation between these, suggesting that this finding is an artefact of our passive survey being conducted in a non-endemic area. Multivariate logistic regression analysis also showed that patients infected with *L tropica* were younger than those infected with L. *major*.

Clinically, there was clear heterogeneity in the appearance of lesions that was not significantly associated with *Leishmania* causing the infection ([Table 2](#t0010){ref-type="table"}). However, the lesions caused by L. *tropica* were significantly smaller (\<2 cm in diameter) than those caused by L. *major*, as previously reported ([@bb0035]). Furthermore, the lesions caused by *L*. *tropica* mostly occurred on the face (*p* = 0.001) and were multiple in 50.8% (31/61) of patients. Multivariate logistic regression analysis showed that small facial lesions were significantly associated with L. *tropica*. Therefore, facial lesions could be a good criterion for predicting the responsible species. [@bb0015] suggested that lower night time temperatures in chronic CL foci in Tunisia can explain the predominance of facial lesions. Classically, *L*. *major* is characterised by multiple lesions that are often contiguous, which may be explained by the inability of *P*. *papatasi* to obtain a sufficient blood meal in a single bite ([@bb0010]). Thus, CL caused by L. *tropica* tended to be linked to multiple lesions, but L. *major* is also characterised by this; therefore, it cannot be used as a diagnostic feature. The clinical appearance of lesions also depends on the immune status of the host and T-lymphocyte response ([@bb0020]) as well as parasite genotype and its burden ([@bb0010]), with experimental infections showing that sandfly salivary antigens affect local host immune responses ([@bb0090]).

Finally, no significant difference was found between the incubation periods of L. *tropica* and L. *major* ([Table 2](#t0010){ref-type="table"}), although this may have been due to unreliable data being obtained through patients\' anamneses. Furthermore, most patients presented with lesions that had been developing for \>2 months (86.9%), with some having been developing for as much as 6 months (33.7%). These delayed medical consultations may be explained, at least in part, by misdiagnosis by physicians in Casablanca, which may have been due to the variety of differential diagnostic criteria for CL or a lack of knowledge about the disease.

5. Conclusion {#s0060}
=============

Our survey of patients diagnosed with CL in Casablanca, which is a non-endemic city, highlighted the potential exposition to *Leishmania* infection when travelling to endemic CL areas. Thus, there is a real need for the implementation of prevention strategies as well as improved health education by informing people and physicians about CL in both endemic and non-endemic regions. The growing mobility of humans from rural to urban areas raises the possibility of emerging CL foci, particularly of L. *tropica* which is responsible for the anthroponotic form in Morocco. On the other hand, we found that the small size and facial location of dermal lesions were the only factors that were significantly associated with CL caused by L. *tropica*. However, an accurate diagnosis is essential because this will lead to the most appropriate treatment being used, which will improve and accelerate the healing process, helping to avoid drug resistance and leading to efficient preventive measures.
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Unlabelled Image
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Results of parasitological diagnosis of patients with cutaneous leishmaniasis caused by *Leishmania tropica* and L. *major* in Casablanca between 2010 and 2016.Unlabelled TableParasitological diagnosisPatients n = 99 (%)*L. tropica*\
n = 61(61.6)*L. major*\
n = 38(38.4)Direct examination Positive31(50.8)15(39.5) Negative14(23.0)19(50.0) Not done16(26.2)4(10.5)Culture Positive37(60.6)16(42.1) Negative24(39.4)22(57.9)

 {#s0085}

Regions visited by patients diagnosed with cutaneous leishmaniasis caused by *Leishmania tropica* and *L. major* in Casablanca between 2010 and 2016.Unlabelled TableRegionsPatients n = 99(%)*L. tropica*\
n = 61(61.6)*L. major*\
n = 38(38.4)Beni Mellal Khenifra12(19.7)1(2.6)Casablanca-Settat--2(5.3)Draa Tafilalet16(26.2)25(65.8)Fes-Meknes9(14.7)2(5.3)Marrakech-Safi10(16.4)3(7.9)Oriental2(3.4)--Rabat Sale Kenitra2(3.3)--Sous Massa4(6.5)5(13.1)Tanger Tetouan Al Hoceima6(9.8)--

 {#s0090}

Evolution of lesions at diagnosis of patients diagnosed with cutaneous leishmaniasis caused by *Leishmania tropica* and *L. major* in Casablanca between 2010 and 2016.Unlabelled TableEvolution of lesions at diagnosis (months)Patients n = 99(%)*L. tropica*\
n = 61(61.6)*L. major*\
n = 38(38.4)\<26(9.9)3(7.9)2--533(54.1)21(55.3)≥ 619(31.1)13(34.2)ND3(4.9)1(2.6)[^5]
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[^1]: CI: confidence interval.

[^2]: Only for patients living in endemic areas.

[^3]: CI: confidence interval.

[^4]: Patients residing in endemic foci were excluded from this analysis.

[^5]: ND: not determined.
